Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

High levels of ERK activity are key for tissue regeneration in spiny mice, and activating ERK can potentially redirect scar-forming healing towards regenerative healing in mammals.

The conclusion is that thorough investigation of hypertension and hormonal dysfunctions is important, and there may be a link between these conditions and cancer.

The chapter explains common scalp conditions, including infections, infestations, and tumors.

Improving PROTAC delivery systems can enhance their effectiveness and speed up their use in medicine.

Reporter characteristics affect detection of hair loss from cancer therapy.

Reporter characteristics affect detection of hair loss from cancer therapy.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

SCUBE3 is a potential target for cancer and alopecia treatment but is challenging to target due to its varied roles.

PPARβ/δ helps yaks adapt to high altitudes by regulating lipid metabolism in their coats.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Abraham's family infertility may have a genetic explanation.

Herbal remedies may help with hair loss but need more research.

Sulforaphane from broccoli may help treat certain cancers, hormone issues, and hair loss.

Chemotherapy worsens nutritional status in breast cancer patients, requiring targeted nutritional strategies.

Nanoformulations improve luteolin's effectiveness as a cancer treatment.

Nanomaterials can significantly improve wound healing and future treatments may include smart, real-time monitoring.

The document concludes that drug repurposing, which is reusing known medicines for new illnesses, can provide faster, cheaper treatment options for various serious diseases, including cancer, COVID-19, and rare diseases.

Manipulating EGFR signaling may help treat hair loss and promote hair growth.

Different types of skin gland tumors have unique genetic traits, which can guide personalized treatments.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Adding celecoxib to chemotherapy improves survival and quality of life for gastric cancer patients with positive COX-2.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Lysophospholipids like LPA and S1P are important for hair growth, immune responses, and vascular development, and could be targeted for treating diseases.

Betacellulin helps blood vessel growth in wounds but delays hair growth.

Brassinosteroids may be useful in treating cancer, infections, and other diseases.

Nanocarriers can improve skin drug delivery but face challenges in clinical use.

Inhibiting HSP90 increases cell adaptability and survival under stress.

KRT80 may worsen cancer by increasing growth and spread, but its full effects on treatment and outcomes need more research.

BMI is a simple, cost-effective tool for screening obesity and related diseases.